Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2025 Publisher: Wockhardt UK Limited, Ash Road North, Wrexham LL13 9UF, United Kingdom
Piperacillin/Tazobactam 4 g/0.5 g Powder for Solution for Infusion.
| Pharmaceutical Form |
|---|
|
Powder for solution for infusion. White to off white powder. |
Each vial contains 4 g piperacillin (as sodium salt) and 0.5 g tazobactam (as sodium salt).
One vial of powder for solution for infusion contains 9.44 mmol (217 mg) of sodium.
For a full list of excipients see section 6.1.
| Active Ingredient |
|---|
|
Piperacillin, a broad spectrum, semisynthetic penicillin exerts bactericidal activity by inhibition of both septum and cell wall synthesis. Tazobactam, a beta-lactam structurally related to penicillins, is an inhibitor of many beta-lactamases, which commonly cause resistance to penicillins and cephalosporins but it does not inhibit AmpC enzymes or metallo beta-lactamases. Tazobactum extends the antibiotic spectrum of piperacillin to include many beta-lactamase-producing bacteria that have acquired resistance to piperacillin alone. |
| List of Excipients |
|---|
|
None. |
Packs of one two, five and ten* Type II glass vial with butyl rubber stopper and aluminium/plastic seal.
* Not all pack sizes may be marketed.
Wockhardt UK Limited, Ash Road North, Wrexham LL13 9UF, United Kingdom
PL 29831/0341
UK: 17 April 2009
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.